Headquartered in New Haven, CT, Achillion is a leading-edge pharmaceutical company advancing multiple candidates with proven mechanisms for the treatment of HCV and a novel complement factor D inhibitor platform. Hepatitis C is a worldwide epidemic affecting more than 150 million individuals. Complement-related diseases comprise a significant market opportunity.
http://www.achillion.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
1.6 seconds
16x16
Achillion Pharmaceuticals, Inc
Ralph Vaccaro
300 Ge●●●●●●Street
New●●●ven , Connecticut, 06511
United States
View this contact
Achillion Pharmaceuticals, Inc
Ralph Vaccaro
300 Ge●●●●●●Street
New●●●ven , Connecticut, 06511
United States
View this contact
Achillion Pharmaceuticals, Inc
Ralph Vaccaro
300 Ge●●●●●●Street
New●●●ven , Connecticut, 06511
United States
View this contact
BUY YOUR DOMAIN
25
YEARS
11
MONTHS
9
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
174
SITE IP
173.203.62.111
LOAD TIME
1.638 sec
SCORE
6.2
Achillion Pharmaceuticals: Home | achillion.com Reviews
https://achillion.com
Headquartered in New Haven, CT, Achillion is a leading-edge pharmaceutical company advancing multiple candidates with proven mechanisms for the treatment of HCV and a novel complement factor D inhibitor platform. Hepatitis C is a worldwide epidemic affecting more than 150 million individuals. Complement-related diseases comprise a significant market opportunity.
Investors | Achillion Pharmaceuticals
Presentations, Fact Sheet,. Life in New Haven. Rooted in the myth of Achilles, the name of Achillion refers to the brave warrior committed to a cause as well as the company’s mission to combat diseases by identifying and exploiting their unique vulnerabilities. Inspiring Science. Innovative Medicine. Mar 8, 2018. Achillion to Present at the Barclays Global Healthcare Conference. Feb 28, 2018. View all press releases ». Mar 15, 2018 at 11:15 AM ET. Barclays Global Healthcare Conference 2018.
Liver Research Consortium
http://www.scliver.com/sponsors.html
SC Liver Research Consortium. Atlas Laboratories and Pharmaceuticals. Fugisawa Health Care Inc. *Now Astellas Pharma US Inc. Fulcrum Pharma *Now Aptiv Solutions. Genetics Institute Inc. *Now Pfizer Inc. Human Genome Sciences Inc. Kadmon Pharmaceuticals *formerly Three Rivers Pharmaceuticals, LLC. Merck and Co. Inc. Mochida Pharmaceutical Co., Ltd. Myogen *Now Gilead Sciences Inc. Ortho Biotech *Now Janssen Biotech Inc. Otsuka Holdings Co., Ltd. Roche Molecular Systems, Inc. SC Liver Research Consortium.
Board of Directors | Achillion Pharmaceuticals
http://ir.achillion.com/directors.cfm
Science & Technology. David I. Scheer. Chairman of the Board. Jason S. Fisherman MD. Gary E. Frashier. Michael D. Kishbauch. Robert L. Van Nostrand. David I. Scheer. Chairman of the Board. Member of the Compensation Committee. Chair of the Nominating Committee. Member of the Strategy and Corp Dev Committee. Back to Board of Directors. Back to Board of Directors. Jason S. Fisherman MD. Dr Fisherman is Managing Director of Synthesis Capital, formerly Advent Healthcare Ventures, a life science venture capit...
SciStore.Com Site Subscription Institutions
http://web.cambridgesoft.com/sitelicense_gallery.cfm?t=Commercial
If your company, school or institution has purchased a Site Subscription, you may be able to receive a software or database subscription for free! The institutions listed below have Site Subscriptions. What is a Site Subscription? Click here to download using your. Website: http:/ revolutionmedicines.com/. Location: Redwood City, USA. Click here to download using your A-tune Software AG. Website: http:/ www.a-tune.de/. Location: Darmstadt, Germany. Click here to download using your Abzena. Click here to ...
Domain Life Science Portfolio Companies | Domain Associates
http://www.domainvc.com/portfolio
3F Therapeutics, Inc. Devices to treat heart valve disorders. Acquired by ATS Medical, Inc. Acquired by Medtronic. Pursuing unique strategies to prevent drug resistance. Http:/ www.achaogen.com. Achillion Pharmaceuticals, Inc. Dedicated to bringing important new treatments to patients with infectious disease. Http:/ www.achillion.com. Acureon Pharmaceuticals, Inc. Acquire and market drugs focused on infectious diseases, transplant and ICU. Http:/ www.acureonpharma.com. Http:/ www.adynxx.com. Developing a...
HR BioTech Connect » Members
http://hrbiotechconnect.com/members
HR Biotech Connect Home. April 2017 Event with Radford – Submit Your Questions for our Speakers. Building a Mission-Driven Organization: May 16th. Building and Maintaining a Strong Company Culture. December 2014: Spotlight on the Changing OFCCP Regulations. February 2014: Building High Performance Teams. February 2015: Insights into Personal and Team Communication. HR Roundtable Meeting: April 18th. June 2014 Meeting: Responding to Your CFO: Self-Funding and ACA Readiness. BioTech Journey through the Pha...
ProQuest Investments - Portfolio
http://www.proquestvc.com/portfolioperfund.asp?fundid=both
Endoscopy systems. Acquired by Gyrus Corporation, now Olympus. Molecularly targeted therapeutics. Acquired by Kyorin. Novel therapeutics for the manegement of asthma. Supportive care for life-threatening conditions. Minimally-invasive tumor biopsy. Acquired by Johnson and Johnson. Protein engineering for improved biologics. Acquired by Pfizer. Small molecule cancer therapeutics. Acquired by Pharmion, now Celgene Corp. Next generation testosterone therapy. Pain and CNS therapeutics. Implantable medical de...
Quaker Partners
http://www.quakerbio.com/portfoliocompanies.html
New Haven, CT. Innovative biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Developing small molecule, orally active drugs to treat lysosomal storage disorders using pharmacological chaperones to selectively bind and "rescue" misfolded target proteins. Advanced computational fragment-based drug design technology for lead generation and optimization. King of Prussia, PA. Acquired by Pfizer in February 2007. Chapel Hill, NC. Developing novel treat...
Quaker Partners
http://www.quakerbioventures.com/portfoliocompanies.html
New Haven, CT. Innovative biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Developing small molecule, orally active drugs to treat lysosomal storage disorders using pharmacological chaperones to selectively bind and "rescue" misfolded target proteins. Advanced computational fragment-based drug design technology for lead generation and optimization. King of Prussia, PA. Acquired by Pfizer in February 2007. Chapel Hill, NC. Developing novel treat...
TOTAL LINKS TO THIS WEBSITE
174
www.achillion-pharmaceuticals.org
www.achillion-pharmaceuticals.us
Restaurant Achillion Wien - Willkommen!
PFANNEN and BACKOFEN SPEZIALITÄTEN. Get the Flash Player. To see this player. Time2online Joomla Extensions: Simple Video Flash Player Module. Wir begrüßen Sie recht herzlich im Restaurant ACHILLION. Die "Kindermilchanstalt" hatte die Aufgabe, Tierhaltung und Milchverarbeitung auf dem für damalige Verhältnisse höchsten hygienischen Niveau zu gewährleisten und die Milch speziell an die Wiener Kinderspitäler auszuliefern. Nachdem im Jahre 1883 viele Weinstöcke der Reblaus zum Opfer gefallen waren, stel...
www.achillion.biz
Achillion Property & Investments - www.achillion.co.uk
Trinity Place, Ramsgate. Portland House, Deal. Prince Of Wales Terrace, Deal. 8 Villas with communal pool. 4 Villa with private pools. 2 Villas with private pools. Villa and Bungalow with private pools. Curzon Square Park Lane. 3 Bed House Wingham. Two Executive Houses Kennington. 5 Bed House Wiltshire. 5 Bed Mansion Tenterden. Pennar Park, Pembrokeshire. Little Burton Farm, Ashford.
Achillion Pharmaceuticals: Home
Complement Factor D Inhibitors. Life in New Haven. Nucleotide NS5B Polymerase Inhibitor. Complement Factor D Inhibitors. Headquartered in New Haven, CT,Achillion applies expertise in biology and structure-guided design and a deep understanding of patient and clinician needs to develop innovative treatment solutions aimed at improving the lives of patients. More. About the Hepatitis C Virus. May 18, 2015. UBS Global Healthcare Conference 2015. June 23, 2015. JMP Securities Life Sciences Conference.
achillion.info
achillion.net
Achillion Engineers & Consultants
achillion.us
SOCIAL ENGAGEMENT